Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program.

Auteurs

Coussement G, Catherine J, Roufosse F

  • Date de publication

    July 2024

  • Type

    Article

  • Review

    J Leukoc Biol

  • Researcher's name

    Roufosse Florence

  • Hôpital

    Hôpital Erasme

  • Service

    Médecine Interne

  • PMID

    38970502

  • DOI

    10.1093/jleuko/qiae152